Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 16 results.
User Information
Export Records
  1. 1.   Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection
  2. Houser, K. V.; Gretebeck, L.; Ying, T.; Wang, Y.; Vogel, L.; Lamirande, E. W.; Bock, K. W.; Moore, I. N.; Dimitrov, D. S.; Subbarao, K.
  3. The Journal of infectious diseases. 2016, 15-May; 213(10): 1557-61.
  1. 2.   Humanized monoclonal antibody against the chemokine CXCL-8 (IL-8) effectively prevents acute lung injury
  2. Bao, Z. Y.; Ye, Q. W.; Gong, W. H.; Xiang, Y.; Wan, H. Y.
  3. International Immunopharmacology. 2010, Feb; 10(2): 259-263.
  1. 3.   The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: Implications for echinocandin therapy in neonates
  2. Hope, W. W.; Mickiene, D.; Petraitis, V.; Petraitiene, R.; Kelaher, A. M.; Hughes, J. E.; Cotton, M. P.; Bacher, J.; Keirns, J. J.; Buell, D.; Heresi, G.; Benjamin, D. K.; Groll, A. H.; Drusano, G. L.; Walsh, T. J.
  3. Journal of Infectious Diseases. 2008 197(1): 163-171.
  1. 4.   Cloning and characterization of guinea pig CXCR1
  2. Takahashi, M.; Jeevan, A.; Sawant, K.; McMurray, D. N.; Yoshimura, T.
  3. Molecular Immunology. 2007, Feb; 44(5): 878-888.
  1. 5.   Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine
  2. Mikszta, J. A.; Dekker, J. P.; Harvey, N. G.; Dean, C. H.; Brittingham, J. M.; Huang, J.; Sullivan, V. J.; Dyas, B.; Roy, C. J.; Ulrich, R. G.
  3. Infection and Immunity. 2006, Dec; 74(12): 6806-6810.
  1. 6.   Triazole-polyene antagonism in experimental invasive pulmonary aspergillosis: In vitro and in vivo correlation
  2. Meletiadis, J.; Petraitis, V.; Petraitiene, R.; Lin, P.; Stergiopoulou, T.; Kelaher, A. M.; Sein, T.; Schaufele, R. L.; Bacher, J.; Walsh, T. J.
  3. Journal of Infectious Diseases. 2006, Oct; 194(7): 1008-1018.
  1. 7.   Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis
  2. Francesconi, A.; Kasai, M.; Petraitiene, R.; Petraitis, V.; Kelaher, A. M.; Schaufele, R.; Hope, W. W.; Shea, Y. R.; Bacher, J.; Walsh, T. J.
  3. Journal of Clinical Microbiology. 2006, Jul; 44(7): 2475-2480.
  1. 8.   Multidimensional volumetric imaging of pulmonary infiltrates for measuring therapeutic response to antifungal therapy in experimental invasive pulmonary aspergillosis
  2. Petraitis, V.; Petraitiene, R.; Solomon, J.; Kelaher, A. M.; Murray, H. A.; Mya-San, C.; Bhandary, A. K.; Sein, T.; Avila, N. A.; Basevicius, A.; Bacher, J.; Walsh, T. J.
  3. Antimicrobial Agents and Chemotherapy. 2006, Apr; 50(4): 1510-1517.
  1. 9.   Activation-induced deaminase cloning, localization, and protein extraction from young V-H-Mutant rabbit appendix
  2. Yang, G. B.; Obiakor, H.; Sinha, R. K.; Newman, B. A.; Hood, B. L.; Conrads, T. P.; Veenstra, T. D.; Mage, R. G.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2005, NOV 22; 102(47): 17083-17088.
  1. 10.   Efficacy, plasma pharmacokinetics, and safety of icofungipen, an inhibitor of Candida isoleucyl-tRNA synthetase, in treatment of experimental disseminated candidiasis in persistently neutropenic rabbits
  2. Petraitiene, R.; Petraitis, V.; Kelaher, A. M.; Sarafandi, A. A.; Mickiene, D.; Groll, A. H.; Sein, T.; Bacher, J.; Walsh, T. J.
  3. Antimicrobial Agents and Chemotherapy. 2005, MAY; 49(5): 2084-2092.
  1. 11.   The CYP2E1-humanized transgenic mouse: Role of CYP2E1 in acetaminophen hepatotoxicity
  2. Cheung, C.; Yu, A. M.; Ward, J. M.; Krausz, K. W.; Akiyama, T. E.; Feigenbaum, L.; Gonzalez, F. J.
  3. Drug Metabolism and Disposition. 2005, MAR; 33(3): 449-457.
  1. 12.   Recombinant guinea pig tumor necrosis factor alpha stimulates the expression of interleukin-12 and the inhibition of Mycobacterium tuberculosis growth in macrophages
  2. Cho, H.; Lasco, T. M.; Allen, S. S.; Yoshimura, T.; McMurray, D. N.
  3. Infection and Immunity. 2005, MAR; 73(3): 1367-1376.
  1. 13.   Efficacy and safety of generic amphotericin B in experimental pulmonary aspergillosis
  2. Petraitis, V.; Petraitiene, R.; Lin, P. X.; Calis, K.; Kelaher, A. M.; Muray, H. A.; Mya-San, C.; Mickiene, D.; Bacher, J.; Walsh, T. J.
  3. Antimicrobial Agents and Chemotherapy. 2005 49(4): 1642-1645.
  1. 14.   Efficacy of PLD-118, a novel inhibitor of Candida isoleucyl-tRNA synthetase, against experimental oropharyngeal and Esophageal candidiasis caused by fluconazole-resistant C albicans
  2. Petraitis, V.; Petraitiene, R.; Kelaher, A. M.; Sarafandi, A. A.; Sein, T.; Mickiene, D.; Bacher, J.; Groll, A. H.; Walsh, T. J.
  3. Antimicrobial Agents and Chemotherapy. 2004, OCT; 48(10): 3959-3967.
  1. 15.   Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction
  2. Walsh, T. J.; Shoham, S.; Petraitiene, R.; Sein, T.; Schaufele, R.; Kelaher, A.; Murray, H.; Mya-San, C.; Bacher, J.; Petraitis, V.
  3. Journal of Clinical Microbiology. 2004, OCT; 42(10): 4744-4748.
  1. 16.   Aluminum, Tau Protein, and Alzheimers-Disease - an Important Link
  2. Savory, J.; Garruto, R. M.
  3. Nutrition. 1998 14(3): 313-314.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel